These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24859392)

  • 21. Are ESPGHAN "biopsy-sparing" guidelines for celiac disease also suitable for asymptomatic patients?
    Trovato CM; Montuori M; Anania C; Barbato M; Vestri AR; Guida S; Oliva S; Mainiero F; Cucchiara S; Valitutti F
    Am J Gastroenterol; 2015 Oct; 110(10):1485-9. PubMed ID: 26372508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Anti-tissue Transglutaminase Antibody Titers and Duodenal Biopsy Findings in Pediatric Patients of Celiac Disease.
    Taneja K; Mahajan N; Rai A; Malik S; Khatri A
    Cureus; 2021 Mar; 13(3):e13679. PubMed ID: 33824830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of no-biopsy pathway for the diagnosis of celiac disease in Asian adults: a multicenter retrospective study.
    Pachisia AV; Kumari A; Mehta S; Ahmed A; Chauhan A; Agarwal A; Dwarkanathan V; Rajpoot S; Prasad S; Kumar S; Sinha SK; Sharma D; Rajput M; Das P; Falodia S; Kochhar R; Ramakrishna BS; Ahuja V; Makharia G
    J Gastroenterol Hepatol; 2024 Mar; 39(3):489-495. PubMed ID: 38095156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease.
    Zanini B; Magni A; Caselani F; Lanzarotto F; Carabellese N; Villanacci V; Ricci C; Lanzini A
    Dig Liver Dis; 2012 Apr; 44(4):280-5. PubMed ID: 22119616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining thresholds of antibody levels improves diagnosis of celiac disease.
    Vermeersch P; Geboes K; Mariën G; Hoffman I; Hiele M; Bossuyt X
    Clin Gastroenterol Hepatol; 2013 Apr; 11(4):398-403; quiz e32. PubMed ID: 23103822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Celiac Disease Diagnosis Without Biopsy: Is a 10× ULN Antitransglutaminase Result Suitable for a Chemiluminescence Method?
    Previtali G; Licini L; D'Antiga L; Marseglia A; Ravasio R; Nembrini F; Greco S; Sonzogni A; Azzarà G; Ravelli P; Alessio MG
    J Pediatr Gastroenterol Nutr; 2018 Apr; 66(4):645-650. PubMed ID: 28991835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening of patients with juvenile idiopathic arthritis and those with rheumatoid arthritis for celiac disease in southwestern Iran.
    Moghtaderi M; Farjadian S; Aflaki E; Honar N; Alyasin S; Babaei M
    Turk J Gastroenterol; 2016 Nov; 27(6):521-524. PubMed ID: 27852543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Celiac disease can be predicted by high levels of anti-tissue transglutaminase antibodies in population-based screening.
    Webb C; Norström F; Myléus A; Ivarsson A; Halvarsson B; Högberg L; Lagerqvist C; Rosén A; Sandström O; Stenhammar L; Carlsson A
    J Pediatr Gastroenterol Nutr; 2015 Jun; 60(6):787-91. PubMed ID: 25564816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationships between Clinical Presentation, Serology, Histology, and Duodenal Deposits of Tissue Transglutaminase Antibodies in Pediatric Celiac Disease.
    Loberman-Nachum N; Schvimer M; Avivi C; Barshack I; Lahad A; Fradkin A; Bujanover Y; Weiss B
    Dig Dis; 2018; 36(5):369-376. PubMed ID: 30016777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of testing patients, on presentation, for serologic features of celiac disease.
    Srinivas M; Basumani P; Podmore G; Shrimpton A; Bardhan KD
    Clin Gastroenterol Hepatol; 2014 Jun; 12(6):946-52. PubMed ID: 24262940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with Type 1 diabetes mellitus.
    Kordonouri O; Dieterich W; Schuppan D; Webert G; Müller C; Sarioglu N; Becker M; Danne T
    Diabet Med; 2000 Jun; 17(6):441-4. PubMed ID: 10975212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue transglutaminase enzyme-linked immunosorbent assay as a screening test for celiac disease in pediatric patients.
    Chan AW; Butzner JD; McKenna R; Fritzler MJ
    Pediatrics; 2001 Jan; 107(1):E8. PubMed ID: 11134472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and clinical significance of IgA anti-tissue transglutaminase antibodies in patients with chronic liver disease.
    Sood A; Khurana MS; Mahajan R; Midha V; Puri S; Kaur A; Gupta N; Sharma S
    J Gastroenterol Hepatol; 2017 Feb; 32(2):446-450. PubMed ID: 27346589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review.
    Husby S; Murray JA; Katzka DA
    Gastroenterology; 2019 Mar; 156(4):885-889. PubMed ID: 30578783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Predictive value of serological tests in the diagnosis of celiac disease].
    Carroccio A; Di Prima L; Falci C; Le Moli C; Soresi M; Montalto G; Notarbartolo A
    Ann Ital Med Int; 2002; 17(2):102-7. PubMed ID: 12150043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations?
    Barker CC; Mitton C; Jevon G; Mock T
    Pediatrics; 2005 May; 115(5):1341-6. PubMed ID: 15867045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive predictive value of serological diagnostic measures in celiac disease.
    Toftedal P; Nielsen C; Madsen JT; Titlestad K; Husby S; Lillevang ST
    Clin Chem Lab Med; 2010 May; 48(5):685-91. PubMed ID: 20201743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility in clinical practice of immunoglobulin a anti-tissue transglutaminase antibody for the diagnosis of celiac disease.
    Abrams JA; Brar P; Diamond B; Rotterdam H; Green PH
    Clin Gastroenterol Hepatol; 2006 Jun; 4(6):726-30. PubMed ID: 16630760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum intestinal fatty acid-binding protein in the noninvasive diagnosis of celiac disease.
    Oldenburger IB; Wolters VM; Kardol-Hoefnagel T; Houwen RHJ; Otten HG
    APMIS; 2018 Mar; 126(3):186-190. PubMed ID: 29383769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice.
    Werkstetter KJ; Korponay-Szabó IR; Popp A; Villanacci V; Salemme M; Heilig G; Lillevang ST; Mearin ML; Ribes-Koninckx C; Thomas A; Troncone R; Filipiak B; Mäki M; Gyimesi J; Najafi M; Dolinšek J; Dydensborg Sander S; Auricchio R; Papadopoulou A; Vécsei A; Szitanyi P; Donat E; Nenna R; Alliet P; Penagini F; Garnier-Lengliné H; Castillejo G; Kurppa K; Shamir R; Hauer AC; Smets F; Corujeira S; van Winckel M; Buderus S; Chong S; Husby S; Koletzko S;
    Gastroenterology; 2017 Oct; 153(4):924-935. PubMed ID: 28624578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.